2013
DOI: 10.1136/ejhpharm-2013-000276.412
|View full text |Cite
|
Sign up to set email alerts
|

OHP-038 Evaluation of Quality of Life in Patients with Multiple Sclerosis: Abstract OHP-038 Table 1

Abstract: The mean value obtained in the questionnaire was 0.71 ± 0.19. Conclusions As has been shown in previous studies, the two dimensions of EuroQoL-5D that most affected the QoL were pain/ discomfort and anxiety/depression. No conflict of interest. Expanding thE involvEmEnt of pharmacy SErvicES via computEriSEd mEdical filES

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles